For clinicians, the nuances of the Phase 3 data matter
GLP-1 receptor agonists increase the risk of cholelithiasis (gallstones)
Common modifications include staying at a dose for 8 weeks instead of 4, adding intermediate steps like 0.375 mg or 0.75 mg, or dropping back a tier if gastrointestinal side effects become severe
According to the FDA-approved prescribing information, injection site reactions occurred in 1.4% of Ozempic patients versus 0.6% in placebo groups
In most cases, occasional ibuprofen use is permitted while taking Zepbound, but it should be done cautiously and with medical guidance, especially for patients prone to stomach irritation
While some people experience rapid, significant weight loss with this medication, others may see more modest results or progress at a slower pace